Summary of treatment-emergent renal events from patients treated with single-agent carfilzomib from four phase II studies in relapsed and/or refractory multiple myeloma.

被引：0
|
作者：
Harvey, R. Donald
Lonial, Sagar
Patel, Priti
McCulloch, Leanne
Niesvizky, Ruben
Kaufman, Jonathan L.
机构：
[1] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[2] Onyx Pharmaceut, San Francisco, CA USA
[3] Cornell Univ, Ctr Excellence Lymphoma & Myeloma, Weill Med Coll, New York Presbyterian Hosp, New York, NY 10021 USA
[4] Emory Univ, Atlanta, GA 30322 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18569
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Hematologic safety data from four phase II studies of single-agent carfilzomib in relapsed and/or refractory multiple myeloma
    Nooka, Ajay K.
    Badros, Ashraf Z.
    Patel, Priti
    McCulloch, Leanne
    Lonial, Sagar
    Kaufman, Jonathan L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Incidence and Management of Renal Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib
    Shah, Jatin J.
    [J]. ONCOLOGY-NEW YORK, 2013, 27 : 19 - 23
  • [3] HEMATOLOGIC SAFETY PROFILE OF SINGLE-AGENT CARFILZOMIB IN PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA FROM FOUR PHASE 2 STUDIES
    Nooka, A.
    [J]. HAEMATOLOGICA, 2012, 97 : 601 - 601
  • [4] Cardiac and pulmonary safety profile of patients with relapsed and/or refractory multiple myeloma from four phase 2 studies of single-agent carfilzomib
    Lonial, Sagar
    Niesvizky, Ruben
    McCulloch, Leanne
    Rajangam, Kanya
    Vij, Ravi
    [J]. LEUKEMIA & LYMPHOMA, 2013, 54 : 19 - 19
  • [5] Cardiac and Pulmonary Safety Profile of Single-Agent Carfilzomib From Four Phase 2 Studies in Patients with Relapsed and/or Refractory Multiple Myeloma
    Lonial, Sagar
    Niesvizky, Ruben
    McCulloch, Leanne
    Rajangam, Kanya
    Vij, Ravi
    [J]. BLOOD, 2012, 120 (21)
  • [6] Management of Hematologic Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib
    Nooka, Ajay K.
    [J]. ONCOLOGY-NEW YORK, 2013, 27 : 11 - 18
  • [7] Overview and Management of Cardiac and Pulmonary Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib
    Wang, Michael
    Cheng, Jie
    [J]. ONCOLOGY-NEW YORK, 2013, 27 : 24 - 30
  • [8] Safety profile of single-agent carfilzomib in patients with relapsed or refractory multiple myeloma from 4 phase ll trials
    Siegel, D.
    Martin, T.
    Nooka, A.
    Harvey, R. D.
    Vij, R.
    Niesvizky, R.
    Badros, A. Z.
    Jagannath, S.
    McCulloch, L.
    Rajangam, K.
    Lenial, S.
    [J]. ONKOLOGIE, 2013, 36 : 39 - 40
  • [9] Incidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomib
    Harvey, R. Donald
    [J]. CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2014, 6 : 87 - 96
  • [10] Safety profile of single-agent carfilzomib in patients with relapsed or refractory multiple myeloma from 4 phase 2 trials
    Siegel, D. S.
    Martin, T.
    Nooka, A.
    Harvey, R. D.
    Vij, R.
    Niesvizky, R.
    Badros, A. Z.
    Jagannath, S.
    McCulloch, L.
    Rajangam, K.
    Lonial, S.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 : 20 - 20
12345